News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
UK’s NICE Rejects Cancer Drug in Clash with Roche (JOBS)
June 26, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON/ZURICH, June 26 (Reuters) - Roche's cancer drug Avastin will not be made available for use on Britain's state health service because the Swiss drugmaker has refused to provide enough information to assess its cost-effectiveness.
Twitter
LinkedIn
Facebook
Email
Print
Europe
Roche
MORE ON THIS TOPIC
Insights
Beyond sunshine: Iberia’s biotech moment has arrived with developing capital networks
June 12, 2026
·
4 min read
·
Jennifer C. Smith-Parker
Insights
Portugal, Spain and the new biotech frontier
June 11, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Job Trends
May layoffs hit nearly 7,000, with most cuts from Takeda, BioNTech
June 11, 2026
·
3 min read
·
Angela Gabriel
Insights
France’s biotech ambition is strong but its scale-up engine still needs work
June 2, 2026
·
3 min read
·
Jennifer C. Smith-Parker
